Seoul National University Hospital Gangnam-Real Time Optical Diagnosis Program 2: Gangnam-READI2

Sponsor
Seoul National University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04350840
Collaborator
(none)
8
1
1
11
0.7

Study Details

Study Description

Brief Summary

Accurate optical diagnosis of colorectal polyps could allow a "resect and discard" strategy based on the results of the optical biopsy. Even though intensive training for optical diagnosis, there is still wide variability in individual endoscopists to meet the PIVI thresholds. The investigators with experience of prior optical diagnosis training perform new education and drill to apply proper high confidence according to their decision time. After the education program, the investigators prospectively evaluate real-time optical biopsy analysis of polyps in 8 academic gastroenterologists.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: feedback
N/A

Detailed Description

This study is an extension of the Gangnam-READI program (NCT02516748) in Seoul National University Hospital Healthcare System Gangnam Center. This study is composed of two periods. First, an education program on predicting polyp histology and real-time optical diagnosis will be performed by 8 endoscopists From February to March 2020. In the second period from April 2020 till October 2020(total 6 months), real-time optical diagnosis with time drill for diminutive and small colorectal polyps will be activated. Endoscopists will have 3 seconds rule to make high confidence diagnosis and have feedbacks on their accuracy of optical diagnosis for polyps per 3 months. The performance will be evaluated by comparing the optically predicted diagnosis with the actual histologic diagnosis. Negative predictive value for the prediction of non-neoplastic polyp and concordance of surveillance intervals for diminutive polyps diagnosed optically with high confidence will be measured. In addition, the characteristics of the endoscopist affecting the performance of optical diagnosis were investigated.

Study Design

Study Type:
Interventional
Actual Enrollment :
8 participants
Allocation:
N/A
Intervention Model:
Sequential Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Performance of Real-time Optical Diagnosis for Colon Polyp According to the Confidence Rate of Endoscopists
Actual Study Start Date :
Feb 1, 2020
Actual Primary Completion Date :
Oct 31, 2020
Actual Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Feedback

Participating endoscopists will make high confidence diagnosis according to their judgment time

Behavioral: feedback
feedback of optical diagnosis performance per 3 month

Outcome Measures

Primary Outcome Measures

  1. PIVI threshold [12 months]

    Negative predictive value for the prediction of nonneoplastic polyp and concordance of surveillance intervals for diminutive polyps diagnosed optically with high confidence

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Board-certified gastroenterologists

  2. Endoscopists who finished ex-vivo optical diagnosis training

Exclusion Criteria:
  1. Inflammatory bowel disease

  2. Previous colon cancer history

  3. Previous colon op. history

  4. Melanosis coli

Contacts and Locations

Locations

Site City State Country Postal Code
1 Healthcare System Gangnam Center, Seoul National University Hospital Seoul Korea, Republic of

Sponsors and Collaborators

  • Seoul National University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Su Jin Chung, Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT04350840
Other Study ID Numbers:
  • H-2001083-1095
First Posted:
Apr 17, 2020
Last Update Posted:
Mar 2, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 2, 2022